Full Press Release Details
We have developed Capture-PCR™ – a novel method for liquid biopsy involving the first reported physical isolation of a class of tumor-derived ctDNA fragments from blood.
Cancer-derived ctDNA fragments are then extracted after removal of all normal background DNA of the same sequence for detection with a simple, low cost PCR test.
Find out more about Capture-PCR™ here.
Related Articles
• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states
Data Showing the Prognostic Value of its Nu.Q® Cancer Test
Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states
• Share
• Tweet
• Share on Facebook
• Share
Subscribe for Volition product updates .
Or, click here for Investor Updates and press releases .
" * " indicates required fields